Skip to content Skip to search Skip to footer
WashU Medicine

Dominantly Inherited Alzheimer Network (DIAN)

Menu
  • Join the Registry
    • Individuals & Families
    • Researchers & Health Professionals
  • For Families
    • Genetic Counseling & Testing
    • Family Conferences
    • Video Gallery
    • Family Voices
    • DIAN in Latin America
    • EXR Newsletter
    • Webinars
    • Resources
    • Brain Donation
    • Message from Our Directors
  • Observational Study
    • Obs Study Sites
    • Study Description
    • Participation
    • Procedures
    • Advisory & Steering Committee
    • Funding: DIAN Obs Study
  • Clinical Trials
    • TU Participating Sites
    • Primary Prevention Trial
    • Secondary Prevention Trial
    • Research Updates
    • Funding
    • DIAN-TU History
  • Our Research
    • For Investigators
    • Our Collaborators
    • Research Fellows
    • DIAN Symposium
    • Pharma Consortium
    • Publications
    • Latin America Expansion
  • About us
    • The DIAN Team
    • Committees
    • Contact
  • News & Updates
Advancements in Alzheimers disease

Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach

Reuters - May 8, 2023 • May 8, 2023
View Content

DIAN

Dominantly Inherited Alzheimer Network

WashU Medicine

660 S. Euclid Ave.

Campus Box 8111

St. Louis, MO 63110

 

Contact Us

Links

  • Investigator Resources
  • Current Participating Sites
  • DIAN Research Updates

Make a Difference

Your thoughtful contribution enables us to continue researching possible treatments and ultimately cures for this devastating disease.

DONATE

©2025 Washington University in St. Louis